[New neuroimaging methods in assessing the activity of neuroinflammation in multiple sclerosis].
Alexey BoykoM B DolgushinM A KaralkinaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The review presents current data on the use of positron emission tomography and single-photon emission computed tomography in multiple sclerosis (MS) to assess the activity of the pathological process, including neuroinflammation, demyelination, activation of microglia, neurodegeneration and local blood flow disorders. These methodologies are a new approach for studying the mechanisms of action and evaluating the clinical effect of disease modifying therapy of MS, especially those capable of penetrating into brain tissue. Among them, the most attention is attracted by cladribine tablets acting on the mechanism of immune reconstitution therapy, most likely with the modulation of immune reactions directly in the brain tissue.
Keyphrases
- multiple sclerosis
- positron emission tomography
- computed tomography
- white matter
- blood flow
- cerebral ischemia
- lipopolysaccharide induced
- traumatic brain injury
- mass spectrometry
- resting state
- magnetic resonance imaging
- inflammatory response
- pet imaging
- lps induced
- pet ct
- cognitive impairment
- ms ms
- magnetic resonance
- contrast enhanced
- big data
- neuropathic pain
- functional connectivity
- stem cells
- bone marrow
- spinal cord injury
- brain injury
- smoking cessation
- replacement therapy